Table 4.
EQ-5D-3L Health Dimensions as Reported by the Study Subjects
| Variable | Mean (±SD) | Number of DRPs (n=1625) | P-value* |
|---|---|---|---|
| Correlation Coefficient** | |||
| HRQoL utility value | 0.62 (±0.27) | −0.237 | <0.001 |
| Domain | Level of the problem | Domain n (%) | |
| Mobility | |||
| 1 | 163 (33.20) | ||
| 2 | 298 (60.69) | ||
| 3 | 30 (6.11) | ||
| Self-care | |||
| 1 | 398 (81.06) | ||
| 2 | 59 (12.02) | ||
| 3 | 34 (6.92) | ||
| Activity | |||
| 1 | 184 (37.47) | ||
| 2 | 182 (37.07) | ||
| 3 | 125 (25.46) | ||
| Pain | |||
| 1 | 159 (32.38) | ||
| 2 | 237 (48.27) | ||
| 3 | 95 (19.35) | ||
| Anxiety | |||
| 1 | 215 (43.79) | ||
| 2 | 185 (37.68) | ||
| 3 | 91 (18.53) | ||
Notes: **HRQoL utility value represented by Spearman correlation coefficient. *Statistical significance was set at a 2-sided P<0.05.
Abbreviations: HRQoL, health-related quality of life; DRPs, drug-related problems.